Therapeutic potential of natural products from terrestrial plants as TNF-α antagonist

Current Topics in Medicinal Chemistry

Volumn 12, Issue 13, 2012, Pages 1422-1435

  Verma, Praveen Kumar ^a   Bala, Manju ^a   Kumar, Neeraj ^a   Singh, Bikram ^a  

^a CSIR INSTITUTE OF HIMALAYAN BIORESOURCE TECHNOLOGY   (India)

Author keywords

Anti inflammatory; Natural products; Tumor necrosis factor alpha

Indexed keywords

ACANTHOIC ACID; ARTEMISOLIDE; BUCHANANINE; CARDAMONIN; CATALPOL; CATALPOSIDE; CELASTROL; CHAMISSONOLIDE; COLUMBIANETIN; CROCETIN; CROCIN; CRYPTOSIN; CURCUMIN; DIDEMETHOXYCURCUMIN; HAMAMELITANNIN; HELENALIN; IMPRESSIC ACID; ISOLIQUIRITIGENIN; LUTEOLIN; NATURAL PRODUCT; OLEANOLIC ACID; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; QUERCETIN; QUERCITRIN; RUTOSIDE; SALVIIFOSIDE; SPECIOSIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACANTHOPANAX; ACANTHOPANAX KOREANUM; ALANGIUM SALVIIFOLIUM; ALPINA OFFICINARUM; ALPINIA RAFFLESIANA; AMOMUM; AMOMUM SUBALATUM; APOCYNACEAE; ARNICA MONTANA; ARTEMISIA SCIATICA; ARTEMISIA SYLVATICA; BARK; BIGNONIACEAE; BORAGINACEAE; CARDIOSPERMUM HALICACABUM; CATALPA OVATE; CELASTRUS; CELASTRUS ORBICULATUS; CENTELLA ASIATICA; CLEMATIS MANDSHURICA; CORNACEAE; CORYDALIS HETEROCARPA; CROCUS SATIVUS; CRYPTOLEPIS BUCHANANI; CURCUMA ZEDOARIA; DIOCLEA ROSTRATA; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; GLOSSOGYNE TENUIFOLIA; GLYCYRRHIZA; HAMAMELIS; HELIOTROPIUM OVALIFOLIUM; HUMAN; HYPERICUM PERFORATUM; MEDICINAL PLANT; NONHUMAN; PAPAVERACEAE; PLANT ROOT; RANUNCULACEAE; REVIEW; SAPINDACEAE; SOYBEAN; TERRESTRIAL SPECIES; TINOSPORA CORDIFOLIA; ZINGIBERACEAE;

ANIMALS; BIOLOGICAL AGENTS; HUMANS; MOLECULAR STRUCTURE; PLANTS, MEDICINAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864535043     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612801784425     Document Type: Review

References (73)

1. Walsh G. Biopharmaceutical: Biochemistry and Biochemistry. Chichester, England: John Wiley & Sons Ltd., 1998, 189-215.
2. Williams, D. A.; Lamke, T. L. Foy's principles of medicinal chemistry. 5th Edition.
3. Carswell, E. A.; Old, L. J.; Kassel, R. L.; Green, S.; Fiore, N.; Williamson, B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. U.S.A., 1975, 72, 3666-3670.
4. Old, L. Tumor necrosis factor (TNF). Science, 1985, 230, 630-632.
5. Pennica, D.; Nedwin, G.; Hayflick, J.; Seeburg, P.; Derynck, R.; Palladino, M.; Kohr, W.; Aggarwal, B.; Goeddel, D. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature, 1984, 312, 724-729.
6. Elliott, M.; Maini, R.; Feldmann, M.; Kalden, J.; Antoni, C.; Smolen, J.; Leeb, B.; Breedveld, F.; Macfarlane, J.; Bijl, H.; Woody, J. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor-α (cA2) versus placebo in rheumatoid arthritis. Lancet, 1994, 344, 1105-1110.
7. Gearing, A. J. H.; Beckett, P.; Christodoulou, M.; Churchill, M.; Clements, J.; Davidson, A. H.; Drummond, A. H.; Galloway, W. A.; Gilbert, R.; Gordon, J. L.; Leber, T. M.; Mangan, M.; Miller, K.; Nayee, P.; Owen, K.; Patel, S.; Thomas, W.; Wells, G.; Wood, L. M.; Woolley, K. Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature, 1994, 370, 555-557.
8. Black, R.; Rauch, C.; Kozlosky, C.; Peschon, J.; Slack, J.; Wolfson, M.; Castner, B.; Stocking, K.; Reddy, P.; Srinivasan, S.; Nelson, N.; Bolani, N.; Schooley, K.; Gerhart, M.; Davis, R.; Fitzner, J.; Johnson, R.; Paxton, R.; March, C.; Cerretti, D. A metalloproteinase disintegrin that releases tumor-necrosis factor-α from cells. Nature, 1997, 385, 729-733.
9. Moss, M.; Jin, S.; Milla, M.; Burkhart, W.; Carter, H.; Chen, W.; Clay, W.; Didsbury, J.; Hassler, D.; Hoffman, C.; Kost, T.; Lambert, M.; Leesnitzer, M.; McCauley, P.; McGeehan, G.; Mitchell, J.; Moyer, M.; Pahel, G.; Rocque, W.; Overton, L.; Schoenen, F.; Seaton, T.; Su, J.; Warner, J.; Willard, D.; Becherer, J. Cloning of a disintegrin metalloproteinase that processes precursor tumournecrosis factor-α. Nature, 1997, 385, 733-736.
10. Hotamisligil, G.; Arner, P.; Caro, J.; Atkinson, R.; Spiegelman, B. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest., 1995, 95, 2409-2415.
11. Selmaj, K.; Raine, C.; Cannella, B.; Brosnan, C. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest., 1991, 87, 949-954.
12. Landow, L.; Andersen, L. Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol. Scand., 1994, 38, 626-639.
13. Miyazaki, Y.; Araki, K.; Vesin, C.; Garcia, I.; Kapanci, Y.; Whitsett, J.; Piguet, P.; Vassalli, P. Expression of a tumor necrosis factor-α transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J. Clin. Invest., 1995, 96, 250-259.
14. Rus, H.; Niculescu, F.; Vlaicu, R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis, 1991, 89, 247-254.
15. Pfeffer, K.; Matsuyama, T.; Kundig, T.; Wakeham, A.; Kishihara, K.; Shahinian, A.; Wiegmann, K.; Ohaski, P.; Kronke, M.; Mak, T. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell, 1993, 73, 457-467.
16. Rothe, J.; Lesslauer, W.; Lotscher, H.; Lang, Y.; Koebel, P.; Kontgen, F.; Althage, A.; Zinkernagel, R.; Steinmetz, M.; Bluethmann, H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature, 1993, 364, 798-802.
17. Mori, L.; Iselin, S.; De Libero, G.; Lesslauer, W. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. J. Immunol., 1996, 157, 3178-3182.
18. Marino, M.; Dunn, A.; Grail, D.; Inglese, M.; Noguchi, Y.; Richards, E.; Jungbluth, A.; Wada, H.; Moore, M.; Williamson, B.; Basu, S.; Old, L. Characterization of tumor necrosis factor deficient mice. Proc. Natl. Acad. Sci. U.S.A., 1997, 94, 8093-8098.
19. Georgopoulos, S.; Plows, D.; Kolias, G. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J. Inflamm., 1996, 46, 86-97.
20. Keffer, J.; Probert, L.; Cazlaris, H.; Georgopoulos, S.; Kaslaris, E.; Kioussis, D.; Kollias, G. Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J., 1991, 10, 4025-4031.
21. Chatzantoni, K.; Mouzaki, A. Anti-TNF-alpha antibody therapies in autoimmune diseases. Curr. Top. Med. Chem., 2006, 6, 1707-1714.
22. Chan, D.S.H.; Lee, H.M.; Yang, F.; Che, C.M.; Wong, C.C.L.; Abagyan, R.; Leung, C.H.; Ma, D.L. Structure-Based Discovery of Natural-Product-like TNF-α Inhibitors. Angew. Chem. Int. Ed., 2010, 49, 2860-2864.
23. Paul, A.T.; Gohil, V.M.; Bhutani, K.K. Modulating TNF-a signaling with natural products. Drug Discovery Today, 2006, 11, 725-732.
24. Kang, O.; Choi, Y.; Park, H.; Kang, C.; Song, B.; Choi, S.; Nah, Y.; Yun, K.; Cai, X.; Kim, Y.; Bae, K.; Lee, Y. Inhibition of tryp sin-induced mast cell activation by acanthoic acid. Journal of Ethnopharmacology, 2006, 105, 326-331.
25. Jeong, A.K.; Seo, Y.Y.; Seok, B.S.; Young, H.K. Effects of Impressic acid from Acanthopanax koreanum on NF-αB and PPARα activities. Arch. Pharm. Res., 2011, 34, 1347-1351.
26. Cai, X.F.; Shen, G.; Dat, N.T.; Kang, O.H.; Lee, Y.M.; Lee, J.J.; Kim, Y.H. Inhibitory effect of kaurane type diterpenoids from Acanthopanax koreanum on TNF-α secretion from trypsinstimulated HMC-1 Cells. Arch. Pharm. Res., 2003, 26, 731-734.
27. Hung, T.M.; Dang, N.H.; Kim, J.C.; Choi, J.S.; Lee, H.K.; Min, B. Phenolic glycosides from Alangium salviifolium leaves with inhibitory activity on LPS-induced NO, PGE2 and TNF-α production. Bioorganic & Medicinal Chemistry Letters, 2009, 19, 4389-4393.
28. Kim, Y.P.; Ban, H.S.; Lim, S.S.; Kimura, N.; Jung, S.H.; Ji, J.; Lee, S.; Ryu, N.; Keum, S.R.; Shin, K.H.; Ohuchi, K. Inhibition of prostaglandin E2 production by 2'-hydroxychalcone derivatives and the mechanism of action. J. Pharm. Pharmacol., 2001, 53, 1295-1302.
29. Ban, H.S.; Suzuki, K.; Lim, S.S.; Jung, S.H.; Lee, S.; Ji, J. Inhibition of lipopolysaccharides-induced expression of inducible nitric oxide synthase and tumor necrosis factor-α by 2'-hydroxychalcone derivatives in RAW 264.7 cells. Biochem. Pharmacol., 2004, 67, 1549-1557.
30. Ahmad, S.; Israf, D.A.; Lajis, N.H.; Shaari, K.; Mohamed, H.; Wahab, A.A.; Ariffin, K.T.; Hoo, W.Y.; Aziz, N.A.; Kadir, A.A.; Sulaiman, M.R.; Somchit, M.N. Cardamonin, inhibits proinflammatory mediators in activated RAW 264.7 cells and whole blood. European Journal of Pharmacology, 2006, 538, 188-194.
31. Yadav, P.N.; Liu, Z.; Rafi, M.M. A diarylheptanoid from lesser galangal (Alpinia officinarum) inhibits proinflammatory mediators via inhibition of mitogen-activated protein kinase, p44/42, and transcription factor nuclear factor-αB. The Journal of Pharmacology and Experimental Therapeutics, 2003, 305, 925-931.
32. Kim, B.H.; Lee, J.Y.; Seo, J.H.; Lee, S.Y.R.; Ahn, B.W.; Lee, C.K.; Hwang, B.Y.; Han, S.B.; Kim, Y. Artemisolide is a typical inhibitor of IαB kinase α targeting cysteine-179 residue and downregulates NF-αB-dependent TNF-α expression in LPS-activated macrophages. Biochemical and Biophysical Research Communications, 2007, 361, 593-598.
33. Jin, H.Z.; Lee, J.H.; Lee, D.; Hong, Y.S.; Kim, Y.H.; Lee, J.J. Inhibitors of the LPS-induced NF-kB activation from Artemisia sylvatica. Phytochemistry, 2004, 65, 2247-2253.
34. Dharmasiri, M.G.; Ratnasooriya, W.D.; Thabrew, M.I. Antiinflammatory activity of decoction of leaves and stems of Anisomeles indica at preflowering and flowering stages. Pharmaceutical Biology, 2002, 40, 433-439.
35. Hsieh, S.C.; Fang, S.H.; Rao, Y.K.; Tzeng, Y.M. Inhibition of proinflammatory mediators and tumor cell proliferation by Anisomeles indica extracts. Journal of Ethnopharmacology, 2008, 118, 65-70.
36. Nam, N.H. Naturally occurring NF-αB inhibitors. Mini Reviews of Medicinal Chemistry, 2006, 6, 945-951.
37. Schroder, H.; Losche, W.; Strobach, H.; Leven, W.; Willuhn, G.; Till, U.; Schror, U. Helenalin and 11 alpha, 13-dihydrohelenalin, two constituents from Arnica montana L., inhibit human platelet function via thiol-dependent pathways. Thromb. Res., 1990, 57, 839-845.
38. Rungeler, P.; Castro, V.; Mora, G.; Goren, N.; Vichnewski, W.; Pahl, H.L.; Merfort, I.; Schmidt, T.J. Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action. Bioorg. Med. Chem., 1999, 7, 2343-2352.
39. Jurg, G.; Otto, S.; Thomas, S.; Jorg, H. Influence of helenanolidetype sesquiterpene lactones on gene transcription profiles in Jurkat T cells and human peripheral blood cells: anti-inflammatory and cytotoxic effects. Biochemical Pharmacology, 2003, 66, 2141-2153.
40. Pae, H.O.; Oh. G.S.; Choi, B.M.; Shin, S.; Chai, K.Y.; Oh, H.; Kim, J.M.; Kim, H.J.; Jang, S.I.; Chung, H.T. Inhibitory effects of the stem bark of Catalpa ovata G. Don. (Bignoniaceae) on the productions of tumor necrosis factor-α and nitric oxide by the lipopolisaccharide-stimulated RAW 264.7 macrophages. Journal of Ethnopharmacology, 2003, 88, 287-291.
41. Gunatilaka, A.A.L. Triterpenoid quinonemethides and related compounds (celastroloids). In: Herz W, Kirby GW, Moore RE, Steglich W, Tamm CH, editors. Progress in the chemistry of organic natural products, vol. 67. Vienna: Springer; 1996. p. 1-176.
42. Allison, A.C.; Cacabelos, R.; Lombardi, V.R.; Alvarez, X.A.; Vigo, C. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog. Neuropsychopharmacol Biol. Psychiatry, 2001, 25, 1341-1357.
43. Chang, F.R.; Hayashi, K.; Chen, I.H.; Liaw, C.C.; Bastow, K.F.; Nakanishi, Y. Antitumor agents. 228. Five new agarofurans, reissantins A-E, and cytotoxic principles from Reissantia buchananii. J. Nat. Prod., 2003, 66, 1416-1420.
44. Lee, J.H.; Koo, T.H.; Yoon, H.; Jung, H.S.; Jin, H.Z.; Lee, K.; Hong, Y.S.; Lee, J.J. Inhibition of NF-kB activation through targeting IkB kinase by celastrol, a quinone methide triterpenoid. Biochemical Pharmacology, 2006, 72, 1311-1321.
45. Giaccio, M. Crocetin from saffron: an active component of an ancient spice. Crit. Rev. Food. Sci. Nutr., 2004, 44, 155-172.
46. Zheng, S.; Qian, Z.; Tang, F.; Sheng, L. Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits. Biochem. Pharmacol., 2005, 70, 1192-9.
47. Xi, L.; Qian, Z.; Shen, X.; Wen, N.; Zhang, Y. Crocetin prevents dexamethasone-induced insulin resistance in rats. Planta Med., 2005, 71, 917-922.
48. Liang, X.; Zhiyu, Q.; Guanglin, X.; Shuguo, Z.; Sai, S.; Na, W.; Liang, S.; Yun, S.; Yabing, Z. Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. Journal of Nutritional Biochemistry, 2007, 18, 64-72.
49. Soeda, S.O.T.; Paopong, L.; Tanaka, H.; Shoyama, Y.; Shimeno, H. Crocin suppresses tumor necrosis factor-alpha-induced cell death of neuronally differentiated PC-12 cells. Life Sci., 2001, 69, 2887-2898.
50. Chen, Y.J.; Dai, Y.S.; Chen, B.F.; Chang, A.; Chen, H.C.; Lin, Y.C.; Chang, K.H.; Lai, Y.L.; Chung, C.H.; Lai, Y.J. The effect of tetradrine and extracts of Centella asiatica on acute radiation dermatitis in rats. Biological Pharmaceutical Bulletin, 1999, 22, 703-706.
51. Babu, T.D.; Kuttan, G.; Padikkala, J. Cytotoxic and anti-tumor properties of certain taxa of Umbelliferae with special reference to Centella asiatica (L.) Urban. Journal of Ethnopharmacology, 1995, 48, 53-57.
52. Shukla, A.; Rasik, A.M.; Jain, G.K.; Shankar, R.; Kulshrestha, D.K.; Dhawan, B.N. In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica. Journal of Ethnopharmacology, 1999, 65, 1-11.
53. Matsuda, H.; Tewtrakul, S.; Morikawa, T.; Nakamura, A.; Yoshikawa, M. Anti-allergic principles from Thai zedoary: structural requirements of cucurminoids for inhibition of degranulation and effect on the release of TNF-α and IL-4 in RBL-2H3 cells. Bioorganic and Medicinal Chemistry, 2004, 12, 5891-5898.
54. Park, E.K.; Ryu, M.H.; Kim, Y.H.; Lee, Y.A. Lee, S.H.; Woo, D.H.; Hong, S.J.; Han, J.S.; Yoo, M.C.; Yang, H.I.; Kim, K.S. Anti-inflammatory effects of an ethanolic extract from Clematis mandshurica Rupr. Journal of Ethnopharmacology, 2006, 108, 142-147.
55. Suh, S.J.; Kim, K.S.; Lee, S.D.; Lee, C.H.; Choi, H.S.; Jin, U.H.; Chang, Y.C.; Kim, C.H. Effects and mechanisms of Clematis mandshurica Maxim. as a dual inhibitor of proinflammatory cytokines on adjuvant arthritis in rats. Environmental Toxicology and Pharmacology, 2006, 22, 205-212.
56. Laupattarakasem, P.; Wangsrimongkol, T.; Surarit, R.; Hahnvajanawong, C. In vitro and in vivo anti-inflammatory potential of Cryptolepis buchanani. Journal of Ethnopharmacology, 2 108, 349-354.
57. Sheeba, M.S.; Asha V.V. Cardiospermum halicacabum ethanol extract inhibits LPS induced COX-2, TNF-α and iNOS expression, which is mediated by NF-αB regulation, in RAW264.7 cells. Journal of Ethnopharmacology, 2009, 124, 39-44.
58. Ruiz, A.P.; Haller, D. Functional diversity of flavonoids in the inhibition of the pro-inflammatory NF-kB, IRF and Akt signaling pathways in Murine Intestinal Epithelial cells. Journal of Nutrition, 2006, 136, 664-671.
59. Kim, J.J.; Kang, T.H.; Seo, J.U.; Na, H.J.; Kim, S.J.; Moon, P.D.; Kim, N.H.; Choi, I.Y.; Myung, N.Y.; Hong, S.H.; Kim, S.H.; Kim, Y.A.; Seo, Y.W.; Kim, M.H.; Park, J.H.; Kang, I.C.; Um, J.Y.; Kim, H.M.; Jeong, H.J. Libanoridin inhibits the mast cell-mediated allergic inflammatory reaction. Immunopharmacology and Immunotoxicology, 2010, 32, 258-264.
60. Kang, K.H.; Kong, C.S.; Seo, Y.; Kim, M.M.; Kim S.K. Antiinflammatory effect of coumarins isolated from Corydalis hetero carpa in HT-29 human colon carcinoma cells. Food and Chemical Toxicology, 2009, 47, 2129-2134.
61. Hicks, T.A.; Smith, C.E.; Nigel Williamson, W.R.; Day, E.H. Potential antiinflammatory compounds 1. Antiinflammatory phenylpiperidine derivatives. Journal of Medicinal Chemistry, 1979, 22, 1460-1464.
62. Figueiredo, J.G.; Bitencourt, F.S.; Mota, M.R.L.; Silvestre, P.P.; Aguiar, C.N.; Benevides, R.G.; Nascimento, K.S.; Moura, T.R.; Dal-Secco, D.; Assreuy, A.M.S.; Cunha, F.Q.; Vale, M.R.; Cavada, B.S.; Alencar, N.M.N. Pharmacological analysis of the neutrophil migration induced by D. rostrata lectin: Involvement of cytokines and nitric oxide. Toxicon, 2009, 54, 736-744.
63. Gertsch, J.; Schoop, R.; Kuenzlea, U.; Suter, A. Echinacea alkylamides modulate TNF-α gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Letters, 2004, 577, 563-569.
64. Kim, H.J.; Tsoy, I.; Park, J.M.; Chung, J.; Shin, S.C.; Chang, K.C. Anthocyanins from soybean seed coat inhibit the expression of TNF-α-induced genes associated with ischemia/reperfusion in endothelial cell by NF-αB-dependent pathway and reduce rat myocardial damages incurred by ischemia and reperfusion in vivo. FEBS Letters, 2006, 580, 1391-1397.
65. Ha, C.L.; Weng, C.Y.; Wang, L.; Lian, T.W.; Wu, M.J. Immunomodulatory effect of Glossogyne tenuifolia in murine peritoneal macrophages and splenocytes. Journal of Ethnopharmacology, 2006, 107, 116-125.
66. Kumar, S.; Sharma, A.; Madan, B.; Singhal, V.; Ghosh, B. Isoliquiritigenin inhibits IkB kinase activity and ROS generation to block TNF-α induced expression of cell adhesion molecules on human endothelial cells. Biochemical Pharmacology, 2007, 73, 1602-1612.
67. Flausino, O.A. Jr.; Zangrossi, H. Jr.; Salgado, J.V.; Viana, M.B. Effects of acute and chronic treatment with Hypericum perforatum L. (IL 160) on different anxiety-related responses in rats. Pharmacol. Biochem. Behav., 2002, 71, 259-265.
68. Menegazzi, M.; Paola, R.D.; Mazzon, E.; Muia, C.; Genovese, T.; Crisafulli, C.; Suzuki, H.; Cuzzocrea, S. Hypericum perforatum attenuates the development of carrageenan-induced lung injury in mice. Free Radical Biology & Medicine, 2006, 40, 740-753.
69. Almeida, A.K.; Suthar, A.; Goswami, H.; Vishwakarma, R.; Chauhan, V.S.; Balkrishnan, A.; Sharma, S. Novel leads from Heliotropium ovalifolium, 4,7,8-trimethoxy-naphthalene-2-carboxylic acid and 6-hydroxy-5,7-dimethoxy-naphthalene-2-carbaldehyde show specific IL-6 inhibitory activity in THP-1 cells and primary human monocytes. Phytomedicine, 2008, 15, 1079-1086.
70. Habtemariam, S. Hamamelitannin from Hamamelis virginiana inhibits the tumor necrosis factor-α (TNF-α)-induced endothelial cell death in vitro. Toxicon, 2002, 40, 83-88.
71. Singh, S.S.; Pandey, S.C.; Srivastava, S.; Gupta, V.S.; Patro, B.; Ghosh, A.C. Chemistry and medicinal properties of Tinospora cordifolia (Guduchi). Indian J Pharmacol, 2003, 35, 83-91.
72. Zalawadia, R.; Gandhi, C.; Patel, V.; Balaraman, R. The protective effect of Tinospora cordifolia on various mast cell mediated allergic reactions. Pharmaceutical Biology, 2009, 47, 1096-1106.
73. Naira, P.K.R.; Rodriguez, S.; Ramachandran, R.; Alamo, A.; Melnick, S.J.; Escalon, E.; Garcia, P.I.; Wnuk, S.F.; Ramachandran, C. Immune stimulating properties of a novel polysaccharide from the medicinal plant Tinospora cordifolia. International Immunopharmacology, 2004, 4, 1645-1659.